MICs shed light on prost...( The body's immune system has built in a...)

The body's immune system has built in anti-tumor mechanisms. In order for cancers to form, one of the molecular steps that must occur is for the tumor cells to develop the means to avoid being attacked by this defense mechanism. There are several different methods by which the immune system can eradicate tumors early in their development. One tumor immune surveillance mechanism utilizes the fact that a specific molecule, the MHC class I chainrelated molecule (MIC), is often expressed on the surface of some tumor cells. MICs interact with the immune system's natural killer cells and trigger them to destroy the tumor cells.

Jennifer Wu and colleagues, at the University of Washington, now investigate how prostate cancers evade this anti-tumor defense strategy. The researchers found that MIC-expressing prostate cancer cell lines were able to activate natural killer cells, thus, initially, this defense mechanism appeared intact. Analysis of prostate tumor biopsies showed that the cell surface localization of MIC was highest in early-stage tumors. The researchers noted that tumors from later-stage patients, however, could no longer activate natural killer cells, and that there were high levels soluble MIC in the blood serum of these patients.

These data showed that the later stage tumors were shedding the MIC from their cell surfaces, and that this was the means by which prostate cancer cells could overcome this particular form of immune surveillance. The deficiency in the ability to activate natural killer cells could be overcome in tissue culture by stimulating the cells with the cytokine IL-2 or IL-15. The authors further investigated how soluble MIC level in serum related to prostate-specific antigen (PSA); PSA measurements are used as a biomarker for the presence of prostate cancer. Soluble MIC serum levels did not correspond with PSA serum levels, but they were highly correlative with high-grade and invasive tumor status in pros
'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
16-Aug-2004

Page: 1 2
Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
3. New fossil sheds light on old mystery
4. Posters highlight water, energy and other natural resource research
5. Select research highlights from current AACR journals
6. Other highlights in the September 1 JNCI
7. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
8. OHSU-VAMC study sheds light on estrogens benefit for MS
9. UV light, coatings reduce bacterial adhesion up to 50 percent
10. Livermore research in accelerator mass spectrometry highlighted at ACS meeting
11. Other highlights in the August 18 JNCI